BETA
Your AI-Trained Oncology Knowledge Connection!
Catherine J. Lee, MD, MS, is an associate professor in the Clinical Research Division at Fred Hutch
Steroid-Refractory Chronic GVHD Background
The categories of steroid refractory gvhd are discussed: intolerant, unresponsive, and dependent.
Treatment Goals for a Patient With Chronic GVHD
The group discusses treatment goals and patient education for chronic GVHD.
Patient Case: A 48-Year-Old Man with Chronic GVHD
Dr Chen and Dr Cutler review a clinical case and discuss GVHD assessment for the patient.
The Chronic GVHD Treatment Paradigm
Dr Lee shares an overview of therapy and supportive care options for chronic GVHD according to the severity of a symptom.
The NIH Clinical Scoring of Organ Systems
Corey Cutler details the NIH Clinical Scoring of Organ System for chronic GHVD symptoms.
Assessment of Chronic GVHD Symptoms
Colleen Danielson, NP, walks through how chronic GVHD symptoms are assessed.
Identification of Patients at High Risk for GVHD
The panelists share their insights on the identification of patients at high risk for GVHD.
Statistics on the Incidence of Chronic GVHD
Dr Chen presents statistics on the incidence of chronic graft versus host disease.
Signs and Symptoms of Acute and Chronic GVHD
Colleen Danielson, NP shares the signs and symptoms she commonly sees in patients with graft versus host disease.
Current GVHD Prophylaxis Strategies
Yi-Bin Chen leads the panel in a review of various GVHD prophylaxis regimens.
Overview of GVHD Risk Factors
Catherine Lee explains risk factors that may contribute to the likelihood of a patient developing graft versus host disease.
Graft versus Host Disease Background
A panel of experts discusses the types of graft versus host disease and the biologic pathways that are thought to be involved.